ORAMED PHARMACEUTICALS INC. (ORMP) Gross margin 2016–2025
ORAMED PHARMACEUTICALS INC. (ORMP) gross margin by fiscal year — reported gross profit divided by reported revenue.
0.7%FY2025 · since FY2016: 23.6% → 0.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 0.7% | — |
| FY2019 | 96.7% | -6.8 pp |
| FY2018 | 103.5% | +11.1 pp |
| FY2017 | 92.4% | +68.8 pp |
| FY2016 | 23.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice